The current MGRX market cap is 14.31M. The company's latest EPS is USD -0.0011 and P/E is -754.55.
Quarter End | |
---|---|
USD ($) | |
Total Revenue | |
Operating Income | |
Net Income |
Year End December 30 2021 | 2021 |
---|---|
USD ($) | |
Total Revenue | 0 |
Operating Income | -18k |
Net Income | -18k |
Quarter End | |
---|---|
USD ($) | |
Total Assets | |
Total Liabilities | |
Total Equity |
Year End December 30 2021 | 2021 |
---|---|
USD ($) | |
Total Assets | 23k |
Total Liabilities | 40k |
Total Equity | -17k |
Market Cap | 14.31M |
Price to Earnings Ratio | -754.55 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 638.46 |
Price to Book Ratio | -831.93 |
Dividend Yield | - |
Shares Outstanding | 17.04M |
Average Volume (1 week) | 228.17k |
Average Volume (1 Month) | 132.81k |
52 Week Change | -80.0% |
52 Week High | 4.2694 |
52 Week Low | 0.42 |
Spread (Intraday) | 0.04 (4.77%) |
Company Name | Mangoceuticals Inc |
Address |
15110 n. dallas parkway, suite 600 dallas, texas 75248 |
Website | https://www.mangorx.com |
Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.